1 975 122 EFFECTS OF AN INTEGRATED YOGA PROGRAMME ON CHEMOTHERAPY-INDUCED NAUSEA AND EMESIS IN BREAST CANCER PATIENTS. THIS STUDY EXAMINED THE EFFECT OF AN INTEGRATED YOGA PROGRAMME ON CHEMOTHERAPY-RELATED NAUSEA AND EMESIS IN EARLY OPERABLE BREAST CANCER OUTPATIENTS. SIXTY-TWO SUBJECTS WERE RANDOMLY ALLOCATED TO RECEIVE YOGA (N = 28) OR SUPPORTIVE THERAPY INTERVENTION (N = 34) DURING THE COURSE OF THEIR CHEMOTHERAPY. BOTH GROUPS HAD SIMILAR SOCIO-DEMOGRAPHIC AND MEDICAL CHARACTERISTICS. INTERVENTION CONSISTED OF BOTH SUPERVISED AND HOME PRACTICE OF YOGA SESSIONS LASTING FOR 60 MIN DAILY, WHILE THE CONTROL GROUP RECEIVED SUPPORTIVE THERAPY AND COPING PREPARATION DURING THEIR HOSPITAL VISITS OVER A COMPLETE COURSE OF CHEMOTHERAPY. THE PRIMARY OUTCOME MEASURE WAS THE MORROW ASSESSMENT OF NAUSEA AND EMESIS (MANE) ASSESSED AFTER THE FOURTH CYCLE OF CHEMOTHERAPY. SECONDARY OUTCOMES INCLUDED MEASURES FOR ANXIETY, DEPRESSION, QUALITY OF LIFE, DISTRESSFUL SYMPTOMS AND TREATMENT-RELATED TOXICITY ASSESSED BEFORE AND DURING THE COURSE OF CHEMOTHERAPY. FOLLOWING YOGA, THERE WAS A SIGNIFICANT DECREASE IN POST-CHEMOTHERAPY-INDUCED NAUSEA FREQUENCY (P = 0.01) AND NAUSEA INTENSITY (P = 0.01), AND INTENSITY OF ANTICIPATORY NAUSEA (P = 0.01) AND ANTICIPATORY VOMITING (P = 0.05) AS COMPARED WITH THE CONTROL GROUP. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN MANE SCORES AND ANXIETY, DEPRESSION AND DISTRESSFUL SYMPTOMS. IN CONCLUSION, THE RESULTS SUGGEST A POSSIBLE USE FOR STRESS REDUCTION INTERVENTIONS SUCH AS YOGA IN COMPLEMENTING CONVENTIONAL ANTIEMETICS TO MANAGE CHEMOTHERAPY-RELATED NAUSEA AND EMESIS. 2007 2 1087 63 EFFECTS OF YOGA ON SYMPTOM MANAGEMENT IN BREAST CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY ON DISTRESSFUL SYMPTOMS IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. MATERIALS AND METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO THEIR RADIOTHERAPY TREATMENT. INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60 MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY ONCE IN 10 DAYS DURING THE COURSE OF THEIR ADJUVANT RADIOTHERAPY. ASSESSMENTS INCLUDED ROTTERDAM SYMPTOM CHECK LIST AND EUROPEAN ORGANIZATION FOR RESEARCH IN THE TREATMENT OF CANCER-QUALITY OF LIFE (EORTC QOL C30) SYMPTOM SCALE. ASSESSMENTS WERE DONE AT BASELINE AND AFTER 6 WEEKS OF RADIOTHERAPY TREATMENT. RESULTS: A GLM REPEATED-MEASURES ANOVA SHOWED A SIGNIFICANT DECREASE IN PSYCHOLOGICAL DISTRESS (P = 0.01), FATIGUE (P = 0.007), INSOMNIA (P = 0.001), AND APPETITE LOSS (P = 0.002) OVER TIME IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS SIGNIFICANT IMPROVEMENT IN THE ACTIVITY LEVEL (P = 0.02) IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN PHYSICAL AND PSYCHOLOGICAL DISTRESS AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, APPETITE LOSS, AND CONSTIPATION. THERE WAS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN THE ACTIVITY LEVEL AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, AND APPETITE LOSS. CONCLUSION: THE RESULTS SUGGEST BENEFICIAL EFFECTS WITH YOGA INTERVENTION IN MANAGING CANCER-AND TREATMENT-RELATED SYMPTOMS IN BREAST CANCER PATIENTS. 2009 3 2156 35 THE EFFECTS OF THE BALI YOGA PROGRAM FOR BREAST CANCER PATIENTS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: RESULTS OF A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL. COMPLEMENTARY AND ALTERNATIVE MEDICINE HAS BEEN SHOWN TO BE BENEFICIAL IN REDUCING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING. HOWEVER, CONCLUSIVE RESULTS ARE LACKING IN ORDER TO CONFIRM ITS USEFULNESS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE WHETHER A STANDARDIZED YOGA INTERVENTION COULD REDUCE THESE ADVERSE SYMPTOMS. THIS WAS A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL COMPARING A STANDARDIZED YOGA INTERVENTION WITH STANDARD CARE. ELIGIBLE PATIENTS WERE ADULTS DIAGNOSED WITH STAGES I TO III BREAST CANCER RECEIVING CHEMOTHERAPY. PATIENTS RANDOMIZED TO THE EXPERIMENTAL GROUP PARTICIPATED IN AN 8-WEEK YOGA PROGRAM. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE EXPERIMENTAL AND CONTROL GROUPS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING AFTER 8 WEEKS. RESULTS SUGGEST THE YOGA PROGRAM IS NOT BENEFICIAL IN MANAGING THESE ADVERSE SYMPTOMS. HOWEVER, CONSIDERING PRELIMINARY EVIDENCE SUGGESTING YOGA'S BENEFICIAL IMPACT IN CANCER SYMPTOM MANAGEMENT, METHODOLOGICAL LIMITATIONS SHOULD BE EXPLORED AND ADDITIONAL STUDIES SHOULD BE CONDUCTED. 2017 4 1818 46 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019 5 189 48 A RANDOMIZED STUDY OF YOGA FOR FATIGUE AND QUALITY OF LIFE IN WOMEN WITH BREAST CANCER UNDERGOING (NEO) ADJUVANT CHEMOTHERAPY. OBJECTIVES: TO COMPARE THE EFFECTIVENESS OF YOGA ADDED TO STANDARD CARE (SC) VERSUS SC ONLY, IN WOMEN WITH BREAST CANCER DURING CHEMOTHERAPY. DESIGN: A MULTICENTER PRAGMATIC, RANDOMIZED CONTROLLED STUDY. SETTINGS/LOCATION: THREE HOSPITALS IN THE NETHERLANDS. SUBJECTS: WOMEN WITH STAGE I-III BREAST CANCER UNDERGOING CHEMOTHERAPY. INTERVENTIONS: WOMEN WERE RANDOMIZED EITHER TO A PROGRAM BASED ON DRU YOGA, ONCE A WEEK YOGA SESSIONS FOR 12 WEEKS (N = 47), OR SC ONLY (N = 36). OUTCOME MEASURES: PRIMARY OUTCOME FATIGUE (MULTIDIMENSIONAL FATIGUE INVENTORY [MFI]; GENERAL FATIGUE) AND SECONDARY OUTCOMES FATIGUE (MFI, FATIGUE QUALITY LIST [FQL]), QUALITY OF LIFE (30-ITEM QUALITY OF LIFE QUESTIONNAIRE-C OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER [EORTC-QLQ-C-30]) AND PSYCHOLOGICAL DISTRESS (HOSPITAL ANXIETY DEPRESSION SCALE [HADS], IMPACT OF EVENTS SCALE [IES]) WERE MEASURED AT BASELINE (T0), 3 MONTHS (T1), AND 6 MONTHS (T2) AND ANALYZED ON OBSERVED CASES. OTHER OUTCOMES WERE ADEQUATE RELIEF, REINTEGRATION TO WORK, AND ADVERSE EVENTS. RESULTS: NO SIGNIFICANT DIFFERENCES WERE FOUND IN GENERAL FATIGUE AT T1 (MFI: YOGA; 14.6 +/- 4.5 VS. SC; 14.2 +/- 4.2, P = 0.987). SIMILAR FINDINGS WERE OBSERVED FOR OTHER FATIGUE (SUB)SCALES OF MFI AND FQL AND FUNCTIONAL DOMAINS OF EORTC. WITH RESPECT TO EORTCS SYMPTOM SCALES, WOMEN IN THE YOGA GROUP REPORTED SIGNIFICANTLY LESS NAUSEA AND VOMITING COMPARED WITH SC AT T2 (P = 0.004), BUT NOT AT T1 (P = 0.807). DEPRESSIVE SYMPTOMS WERE SIGNIFICANTLY LOWER WITH YOGA AT T1 (HADS: YOGA; 4.7 +/- 4.1 VS. SC; 5.1 +/- 4.2, P = 0.031). MORE WOMEN IN THE YOGA GROUP EXPERIENCED ADEQUATE RELIEF COMPARED WITH SC AT T1 (YOGA; 51% VS. SC; 19%) AND HAD RETURNED TO WORK AT T2 (YOGA; 53% VS. SC; 23%). NO ADVERSE EVENTS WERE REPORTED WITH YOGA. CONCLUSIONS: A DRU-BASED YOGA PROGRAM FAILED TO DEMONSTRATE A SIGNIFICANT BENEFICIAL EFFECT ON FATIGUE. POSSIBLE FAVORABLE EFFECTS OF THE YOGA PROGRAM ON NAUSEA AND VOMITING AND EARLY RETURN TO WORK IN BREAST CANCER SURVIVORS WARRANT FURTHER RESEARCH. 2018 6 483 31 CLINICAL EFFICACY OF VAMANA KARMA WITH IKSHWAAKU BEEJA YOGA FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF ARTAVA KSHAYA W. S. R TO POLYCYSTIC OVARIAN SYNDROME. BACKGROUND: DUE TO SEDENTARY LIFESTYLE AND STRESS, THE INCIDENCE OF METABOLIC DISORDERS ARE INCREASING DAY BY DAY. AMONG THESE POLYCYSTIC OVARIAN SYNDROME (PCOS) IS AN INTRICATE DISORDER AFFECTING 4%-8% WOMEN IN THEIR REPRODUCTIVE AGE AND RELATED TO OVARIAN DYSFUNCTION CHARACTERIZED BY OBESITY, OLIGOMENORRHEA, ANOVULATION AND HYPERANDROGENISM. IN MODERN SYSTEM OF MEDICINE, THE AVAILABLE ALLOPATHIC REGIMEN HAS ITS OWN LIMITATIONS, SO IT IS NEED OF TIME TO FIND A SAFE AND EFFECTIVE ALTERNATIVE THERAPY FOR SUCH TYPE OF CONDITION. THE MOST COMMON SYMPTOM IN 85%-90% OF PCOS PATIENTS IS OLIGOMENORRHEA WHICH CAN BE CORRELATED TO ARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) IN AYURVEDA. HENCE, IN THE PRESENT CLINICAL STUDY, VAMANA KARMA (THERAPEUTIC VOMITING) WITH IKSHWAAKU SEED FORMULATION FOLLOWED BY SHATAPUSHPADI GHANAVATI WAS PLANNED. AIMS: TO EVALUATE THE EFFICACY OF VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF AARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) W. S. R TO PCOS. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS OF PCOS WERE CLINICALLY DIAGNOSED AND TREATED BY VAMANA KARMA (THERAPEUTIC VOMITING) PROCEDURE WITH IKSHWAAKU SEED FORMULATION. AFTER COMPLETION OF VAMANA KARMA (THERAPEUTIC VOMITING) AND SAMSARJANA KRAMA, (POST THERAPY DIETARY REGIMEN FOR REVIVAL) SHATAPUSHPADI GHANAVATI 2 VATI (EACH 500 MG) TWICE IN A DAY WITH LUKEWARM WATER WAS GIVEN FOR 45 DAYS. AFTER COMPLETION OF 2-MONTH TRIAL, ASSESSMENT OF THERAPY WAS ESTIMATED BY SUBJECTIVE AND OBJECTIVE PARAMETERS. RESULTS: STATISTICALLY EXTREMELY SIGNIFICANT (P < 0.0001) RESULTS WERE FOUND IN MENSTRUAL IRREGULARITIES, OBESITY, AND BODY MASS INDEX. THE SIGNIFICANT RESULT IN REDUCTION OF NONDOMINANT FOLLICLES (P = 0.01 AND 0.03 FOR RIGHT AND LEFT OVARY, RESPECTIVELY), LOWERING THE FASTING BLOOD SUGAR LEVEL (P = 0.02) AND HIRSUTISM (P = 0.03) WAS FOUND. CONCLUSION: VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IS VERY EFFECTIVE IN THE MANAGEMENT OF OBESE PCOS PATIENTS AND INCREASING CHANCES OF CONCEPTION. 2017 7 774 34 EFFECT OF YOGA AND NATUROPATHY ON DISEASE ACTIVITY AND SYMPTOM BURDENS IN A PATIENT WITH ACTIVE ULCERATIVE COLITIS: A CASE REPORT. OBJECTIVES: ULCERATIVE COLITIS (UC) IS A CHRONIC IDIOPATHIC INFLAMMATORY DISEASE THAT AFFECTS THE LARGE BOWEL. THE OBJECTIVE OF THIS STUDY IS TO FIND THE EFFECT OF YOGA AND NATUROPATHY (YN) IN A PATIENT WITH ACTIVE MODERATE PANCOLITIS. CASE PRESENTATION: AN 18-YEAR OLD UNMARRIED FEMALE DIAGNOSED WITH UC IN 2017. PATIENT'S SYMPTOMS BEGAN WITH ABDOMINAL PAIN, NAUSEA, VOMITING AND DIARRHEA WITH/WITHOUT BLOOD STAINS MORE THAN SEVEN TIMES A DAY, DAILY. THE SYMPTOMS REDUCED AFTER TAKING REGULAR CONVENTIONAL MEDICATION FOR A PERIOD OF ONE-YEAR. HOWEVER, IN FEBRUARY-2019, THE PATIENT VISITED OUR HOSPITAL WITH THE SAME COMPLAINTS AND RECEIVED 21-DAYS OF YN TREATMENTS. RESULTS SHOWED A BETTER REDUCTION IN THE ABDOMINAL PAIN, DISEASE ACTIVITY, STRESS AND DEPRESSION AND A BETTER IMPROVEMENT IN HEMOGLOBIN LEVELS, QUALITY OF SLEEP, AND QUALITY OF LIFE WITH NO ADVERSE EFFECTS. CONCLUSIONS: YN COULD BE CONSIDERED AS AN ALTERNATIVE THERAPY IN THE MANAGEMENT OF UC. HOWEVER, FURTHER STUDIES ARE REQUIRED TO WARRANT THIS EFFECT. 2021 8 329 62 ANXIOLYTIC EFFECTS OF A YOGA PROGRAM IN EARLY BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE ANXIOLYTIC EFFECTS OF A YOGA PROGRAM AND SUPPORTIVE THERAPY IN BREAST CANCER OUTPATIENTS UNDERGOING CONVENTIONAL TREATMENT AT A CANCER CENTRE. METHODS: NINETY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N=45) OR BRIEF SUPPORTIVE THERAPY (N=53) PRIOR TO THEIR PRIMARY TREATMENT I.E., SURGERY. ONLY THOSE SUBJECTS WHO RECEIVED SURGERY FOLLOWED BY ADJUVANT RADIOTHERAPY AND SIX CYCLES OF CHEMOTHERAPY WERE CHOSEN FOR ANALYSIS FOLLOWING INTERVENTION (YOGA, N=18, CONTROL, N=20). INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY DURING THEIR HOSPITAL VISITS AS A PART OF ROUTINE CARE. ASSESSMENTS INCLUDED SPEILBERGER'S STATE TRAIT ANXIETY INVENTORY AND SYMPTOM CHECKLIST. ASSESSMENTS WERE DONE AT BASELINE, AFTER SURGERY, BEFORE, DURING, AND AFTER RADIOTHERAPY AND CHEMOTHERAPY. RESULTS: A GLM-REPEATED MEASURES ANOVA SHOWED OVERALL DECREASE IN BOTH SELF-REPORTED STATE ANXIETY (P<0.001) AND TRAIT ANXIETY (P=0.005) IN YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A POSITIVE CORRELATION BETWEEN ANXIETY STATES AND TRAITS WITH SYMPTOM SEVERITY AND DISTRESS DURING CONVENTIONAL TREATMENT INTERVALS. CONCLUSION: THE RESULTS SUGGEST THAT YOGA CAN BE USED FOR MANAGING TREATMENT-RELATED SYMPTOMS AND ANXIETY IN BREAST CANCER OUTPATIENTS. 2009 9 704 24 EFFECT OF INTEGRATED APPROACH OF YOGA AND NATUROPATHY ON POLYCYSTIC OVARIAN SYNDROME: A CASE STUDY. OWING TO STRESS, SEDENTARY LIFESTYLE AND CHANGES IN DIET PATTERN, THERE IS AN INCREASE IN THE SURGE OF LIFESTYLE AND METABOLIC DISORDERS. POLYCYSTIC OVARIAN SYNDROME (PCOS) AFFECTS 8-13% OF REPRODUCTIVE-AGED WOMEN. PCOS IS CHARACTERISED BY MENSTRUAL IRREGULARITY, HYPERANDROGENISM AND POLYCYSTIC OVARIAN MORPHOLOGY (PCOM). THE EFFICACY OF YOGA AS A THERAPY TO TACKLE THE DIRECT AND INDIRECT CAUSE OF AILMENT IN THE MANAGEMENT OF PCOS IS TO BE DOCUMENTED. THIS IS THE CASE STUDY OF A FEMALE PATIENT AGE 25 YEARS, A DIAGNOSED CASE OF PCOS WAS REGISTERED AT THE AYURVEDA, YOGA, UNANI,SIDDHA,HOMEOPATHY (AYUSH), YOGA OPD, WITH COMPLAINTS OF IRREGULAR MENSTRUATION, TREATED SUCCESSFULLY BY YOGA AND NATUROPATHY (Y AND N), I.E., YOGA, DIET AND LIFESTYLE MODIFICATION. THIS IS EVIDENT FROM THE REDUCTION IN WEIGHT, REGULARISATION OF THE MENSTRUAL CYCLE ALONG WITH MORPHOLOGICAL CHANGES IN THE OVARY AFTER A FOLLOW-UP OF 6 MONTHS. 2022 10 964 69 EFFECTS OF A YOGA PROGRAM ON MOOD STATES, QUALITY OF LIFE, AND TOXICITY IN BREAST CANCER PATIENTS RECEIVING CONVENTIONAL TREATMENT: A RANDOMIZED CONTROLLED TRIAL. AIMS: THE AIM OF THIS STUDY IS TO COMPARE THE EFFECTS OF YOGA PROGRAM WITH SUPPORTIVE THERAPY COUNSELING ON MOOD STATES, TREATMENT-RELATED SYMPTOMS, TOXICITY, AND QUALITY OF LIFE IN STAGE II AND III BREAST CANCER PATIENTS ON CONVENTIONAL TREATMENT. METHODS: NINETY-EIGHT STAGE II AND III BREAST CANCER PATIENTS UNDERWENT SURGERY FOLLOWED BY ADJUVANT RADIOTHERAPY (RT) OR CHEMOTHERAPY (CT) OR BOTH AT A CANCER CENTER WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 45) AND SUPPORTIVE THERAPY COUNSELING (N = 53) OVER A 24-WEEK PERIOD. INTERVENTION CONSISTED OF 60-MIN YOGA SESSIONS, DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY DURING THEIR HOSPITAL VISITS. ASSESSMENTS INCLUDED STATE-TRAIT ANXIETY INVENTORY, BECK'S DEPRESSION INVENTORY, SYMPTOM CHECKLIST, COMMON TOXICITY CRITERIA, AND FUNCTIONAL LIVING INDEX-CANCER. ASSESSMENTS WERE DONE AT BASELINE, AFTER SURGERY, BEFORE, DURING, AND AFTER RT AND SIX CYCLES OF CT. RESULTS: BOTH GROUPS HAD SIMILAR BASELINE SCORES. THERE WERE 29 DROPOUTS 12 (YOGA) AND 17 (CONTROLS) FOLLOWING SURGERY. SIXTY-NINE PARTICIPANTS CONTRIBUTED DATA TO THE CURRENT ANALYSIS (33 IN YOGA, AND 36 IN CONTROLS). AN ANCOVA, ADJUSTING FOR BASELINE DIFFERENCES, SHOWED A SIGNIFICANT DECREASE FOR THE YOGA INTERVENTION AS COMPARED TO THE CONTROL GROUP DURING RT (FIRST RESULT) AND CT (SECOND RESULT), IN (I) ANXIETY STATE BY 4.72 AND 7.7 POINTS, (II) DEPRESSION BY 5.74 AND 7.25 POINTS, (III) TREATMENT-RELATED SYMPTOMS BY 2.34 AND 2.97 POINTS, (IV) SEVERITY OF SYMPTOMS BY 6.43 AND 8.83 POINTS, (V) DISTRESS BY 7.19 AND 13.11 POINTS, AND (VI) AND IMPROVED OVERALL QUALITY OF LIFE BY 23.9 AND 31.2 POINTS AS COMPARED TO CONTROLS. TOXICITY WAS SIGNIFICANTLY LESS IN THE YOGA GROUP (P = 0.01) DURING CT. CONCLUSION: THE RESULTS SUGGEST A POSSIBLE USE FOR YOGA AS A PSYCHOTHERAPEUTIC INTERVENTION IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT. 2017 11 1525 23 IYENGAR YOGA AND THE USE OF PROPS FOR PEDIATRIC CHRONIC PAIN: A CASE STUDY. IYENGAR YOGA USES POSTURES AND PROPS TO SUPPORT THE BODY SO THAT PRACTITIONERS CAN ENGAGE IN POSES THAT WOULD OTHERWISE BE MORE DIFFICULT. THIS TYPE OF YOGA MAY BE USEFUL IN TREATING CHILDREN AND ADOLESCENTS WHO HAVE CHRONIC PAIN AND DISABILITY. IN THIS CASE STUDY, THE AUTHORS DISCUSS A 14-Y-OLD GIRL WHO HAD TWO SURGERIES FOR GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) AND WHO HAD CONTINUED CHEST AND ABDOMINAL PAIN, AS WELL AS VOMITING, DIFFICULTY EATING, WEIGHT LOSS, AND ANXIETY. HAVING SIGNIFICANTLY IMPAIRED FUNCTIONING, SHE WAS UNABLE TO ATTEND SCHOOL, SLEEP, SOCIALIZE, OR EAT, AND SHE HAD BECOME WHEELCHAIR-BOUND. DESPITE EVALUATIONS AND TREATMENTS BY SPECIALISTS OVER AN EXTENDED PERIOD OF TIME, HER SYMPTOMS HAD NOT IMPROVED. THIS CASE HISTORY DESCRIBES HOW THE AUTHORS USED A 4-MO TREATMENT OF IYENGAR YOGA TO HELP THE ADOLESCENT RESUME ACTIVITIES AND RE-ENGAGE WITH HER ENVIRONMENT. THE AUTHORS INTEND THIS REPORT TO STIMULATE SCIENTIFIC STUDY OF THIS FORM OF TREATMENT FOR CHILDREN AND ADOLESCENTS WITH CHRONIC PAIN. 2013 12 1097 61 EFFECTS OF YOGA PROGRAM ON QUALITY OF LIFE AND AFFECT IN EARLY BREAST CANCER PATIENTS UNDERGOING ADJUVANT RADIOTHERAPY: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY AT A CANCER CENTRE. METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO THEIR RADIOTHERAPY TREATMENT. INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60 MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY ONCE IN 10 DAYS. ASSESSMENTS INCLUDED EUROPEAN ORGANIZATION FOR RESEARCH IN THE TREATMENT OF CANCER-QUALITY OF LIFE (EORTCQOL C30) FUNCTIONAL SCALES AND POSITIVE AND NEGATIVE AFFECT SCHEDULE (PANAS). ASSESSMENTS WERE DONE AT BASELINE AND AFTER 6 WEEKS OF RADIOTHERAPY TREATMENT. RESULTS: AN INTENTION TO TREAT GLM REPEATED MEASURES ANOVA SHOWED SIGNIFICANT DIFFERENCE ACROSS GROUPS OVER TIME FOR POSITIVE AFFECT, NEGATIVE AFFECT AND EMOTIONAL FUNCTION AND SOCIAL FUNCTION. THERE WAS SIGNIFICANT IMPROVEMENT IN POSITIVE AFFECT (ES = 0.59, P = 0.007, 95%CI 1.25 TO 7.8), EMOTIONAL FUNCTION (ES = 0.71, P = 0.001, 95%CI 6.45 TO 25.33) AND COGNITIVE FUNCTION (ES = 0.48, P = 0.03, 95%CI 1.2 TO 18.5), AND DECREASE IN NEGATIVE AFFECT (ES = 0.84, P<0.001, 95%CI -13.4 TO -4.4) IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN POSITIVE AFFECT WITH ROLE FUNCTION, SOCIAL FUNCTION AND GLOBAL QUALITY OF LIFE. THERE WAS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN NEGATIVE AFFECT WITH PHYSICAL FUNCTION, ROLE FUNCTION, EMOTIONAL FUNCTION AND SOCIAL FUNCTION. CONCLUSION: THE RESULTS SUGGEST A POSSIBLE ROLE FOR YOGA TO IMPROVE QUALITY OF LIFE AND AFFECT IN BREAST CANCER OUTPATIENTS. 2009 13 974 65 EFFECTS OF AN INTEGRATED YOGA PROGRAM ON SELF-REPORTED DEPRESSION SCORES IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT: A RANDOMIZED CONTROLLED TRIAL. AIM: TO COMPARE THE EFFECTS OF YOGA PROGRAM WITH SUPPORTIVE THERAPY ON SELF-REPORTED SYMPTOMS OF DEPRESSION IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT. PATIENTS AND METHODS: NINETY-EIGHT BREAST CANCER PATIENTS WITH STAGE II AND III DISEASE FROM A CANCER CENTER WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 45) AND SUPPORTIVE THERAPY (N = 53) OVER A 24-WEEK PERIOD DURING WHICH THEY UNDERWENT SURGERY FOLLOWED BY ADJUVANT RADIOTHERAPY (RT) OR CHEMOTHERAPY (CT) OR BOTH. THE STUDY STOPPAGE CRITERIA WAS PROGRESSIVE DISEASE RENDERING THE PATIENT BEDRIDDEN OR ANY PHYSICAL MUSCULOSKELETAL INJURY RESULTING FROM INTERVENTION OR LESS THAN 60% ATTENDANCE TO YOGA INTERVENTION. SUBJECTS UNDERWENT YOGA INTERVENTION FOR 60 MIN DAILY WITH CONTROL GROUP UNDERGOING SUPPORTIVE THERAPY DURING THEIR HOSPITAL VISITS. BECK'S DEPRESSION INVENTORY (BDI) AND SYMPTOM CHECKLIST WERE ASSESSED AT BASELINE, AFTER SURGERY, BEFORE, DURING, AND AFTER RT AND SIX CYCLES OF CT. WE USED ANALYSIS OF COVARIANCE (INTENT-TO-TREAT) TO STUDY THE EFFECTS OF INTERVENTION ON DEPRESSION SCORES AND PEARSON CORRELATION ANALYSES TO EVALUATE THE BIVARIATE RELATIONSHIPS. RESULTS: A TOTAL OF 69 PARTICIPANTS CONTRIBUTED DATA TO THE CURRENT ANALYSIS (YOGA, N = 33, AND CONTROLS, N = 36). THERE WAS 29% ATTRITION IN THIS STUDY. THE RESULTS SUGGEST AN OVERALL DECREASE IN SELF-REPORTED DEPRESSION WITH TIME IN BOTH THE GROUPS. THERE WAS A SIGNIFICANT DECREASE IN DEPRESSION SCORES IN THE YOGA GROUP AS COMPARED TO CONTROLS FOLLOWING SURGERY, RT, AND CT (P < 0.01). THERE WAS A POSITIVE CORRELATION (P < 0.001) BETWEEN DEPRESSION SCORES WITH SYMPTOM SEVERITY AND DISTRESS DURING SURGERY, RT, AND CT. CONCLUSION: THE RESULTS SUGGEST POSSIBLE ANTIDEPRESSANT EFFECTS WITH YOGA INTERVENTION IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT. 2015 14 929 41 EFFECTIVENESS OF YOGA ON QUALITY OF LIFE OF BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A RANDOMIZED CLINICAL CONTROLLED STUDY. BACKGROUND: CANCER OF BREAST IS MOST COMMON CANCER AMONG WOMEN IN INDIA AND VAST MAJORITY OF COUNTRIES WORLDWIDE. WHILE UNDERGOING CHEMOTHERAPY FOR CARCINOMA MANAGEMENT, WOMEN ENCOUNTER SIDE EFFECTS, WHICH AFFECTS THEIR QUALITY OF LIFE (QOL). A RANDOMIZED CONTROLLED STUDY WITH QUANTITATIVE RESEARCH APPROACH AND TIME SERIES DESIGN WAS CONDUCTED, TO STUDY THE EFFECTIVENESS OF YOGA ON QOL OF BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY. METHODOLOGY: ONE HUNDRED BREAST CANCER PATIENTS SCHEDULED FOR 3-WEEKLY, DAY-CARE ADJUVANT CHEMOTHERAPY (CEF REGIMEN) WERE ENROLLED WITH CONSECUTIVE SAMPLING TECHNIQUE, INTO CONTROL (N = 52) AND EXPERIMENT (N = 48) GROUPS, BY CONCEALED RANDOMIZATION FOLLOWING WRITTEN INFORMED CONSENT. BASELINE DATA ON QOL WERE COLLECTED BEFORE FIRST-CYCLE CHEMOTHERAPY USING THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QLQ C30. PATIENTS IN THE EXPERIMENTAL GROUP WERE TAUGHT DIAPHRAGMATIC BREATHING TECHNIQUES, SYSTEMATIC RELAXATION, AND ALTERNATE NOSTRIL BREATHING, AND JOINTS AND GLANDS NECK AND SHOULDER EXERCISES WERE INSTRUCTED TO PRACTICE TWICE DAILY AT HOME. THEY WERE SUPERVISED IN PRACTICING THESE TECHNIQUES WHILE THEY RECEIVED SECOND, THIRD, FOURTH, FIFTH, AND SIXTH CYCLES OF CHEMOTHERAPY IN THE DAY-CARE FACILITY. PARTICIPANTS IN THE CONTROL GROUP RECEIVED ONLY ROUTINE CARE. ALL PARTICIPANTS RECEIVED STANDARD POST CHEMOTHERAPY PRESCRIPTION. DATA ON QOL WERE COLLECTED FROM ALL PATIENTS DURING THE SECOND, THIRD, FOURTH, FIFTH, AND SIXTH CYCLES OF CHEMOTHERAPY. RESULTS: THE ANALYSIS REVEALED THAT AT THE BASELINE (FIRST CHEMOTHERAPY CYCLE), BREAST CANCER PATIENTS IN CONTROL AND EXPERIMENTAL GROUPS WERE HOMOGENEOUS IN TERMS OF THEIR SOCIODEMOGRAPHIC AND CLINICAL VARIABLES AND QOL SCORE. YOGA PRACTICES WERE EFFECTIVE IN IMPROVING THE QOL OF BREAST CANCER PATIENTS IN THE EXPERIMENTAL GROUP IN THE AREAS OF GLOBAL HEALTH STATUS, PHYSICAL FUNCTION, ROLE FUNCTION, AND EMOTIONAL FUNCTION AND DECREASING THE SYMPTOMS OF FATIGUE, INSOMNIA, LOSS OF APPETITE, AND CONSTIPATION, DURING THE PERIOD OF CHEMOTHERAPY. CONCLUSION: YOGA PRACTICES COMPRISING OF RELAXATION TECHNIQUES REDUCE MANY SIDE EFFECTS AND IMPROVE THE QOL OF WOMEN UNDERGOING CHEMOTHERAPY FOR BREAST CANCER. 2020 15 1534 42 IYENGAR-YOGA COMPARED TO EXERCISE AS A THERAPEUTIC INTERVENTION DURING (NEO)ADJUVANT THERAPY IN WOMEN WITH STAGE I-III BREAST CANCER: HEALTH-RELATED QUALITY OF LIFE, MINDFULNESS, SPIRITUALITY, LIFE SATISFACTION, AND CANCER-RELATED FATIGUE. THIS STUDY AIMS TO TEST THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE, LIFE SATISFACTION, CANCER-RELATED FATIGUE, MINDFULNESS, AND SPIRITUALITY COMPARED TO CONVENTIONAL THERAPEUTIC EXERCISES DURING (NEO)ADJUVANT CYTOTOXIC AND ENDOCRINE THERAPY IN WOMEN WITH BREAST CANCER. IN A RANDOMIZED CONTROLLED TRIAL 92 WOMEN WITH BREAST CANCER UNDERGOING ONCOLOGICAL TREATMENT WERE RANDOMLY ENROLLED FOR A YOGA INTERVENTION (YI) (N = 45) OR FOR A PHYSICAL EXERCISE INTERVENTION (PEI) (N = 47). MEASUREMENTS WERE OBTAINED BEFORE (T 0) AND AFTER THE INTERVENTION (T 1) AS WELL AS 3 MONTHS AFTER FINISHING INTERVENTION (T 2) USING STANDARDIZED QUESTIONNAIRES. LIFE SATISFACTION AND FATIGUE IMPROVED UNDER PEI (P < 0.05) BUT NOT UNDER YI (T 0 TO T 2). REGARDING QUALITY OF LIFE (EORTC QLQ-C30) A DIRECT EFFECT (T 0 TO T 1; P < 0.001) OF YI WAS FOUND ON ROLE AND EMOTIONAL FUNCTIONING, WHILE UNDER PEI ONLY EMOTIONAL FUNCTIONING IMPROVED. SIGNIFICANT IMPROVEMENTS (P < 0.001) WERE OBSERVED AT BOTH T 1 AND T 2 ALSO FOR SYMPTOM SCALES IN BOTH GROUPS: DYSPNEA, APPETITE LOSS, CONSTIPATION, AND DIARRHEA. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THERAPIES FOR NONE OF THE ANALYZED VARIABLES NEITHER FOR T 1 NOR FOR T 2. DURING CHEMOTHERAPY, YOGA WAS NOT SEEN AS MORE HELPFUL THAN CONVENTIONAL THERAPEUTIC EXERCISES. THIS DOES NOT ARGUE AGAINST ITS USE IN THE RECOVERY PHASE. 2016 16 2530 34 YOGA EFFECTS ON ANTHROPOMETRIC INDICES AND POLYCYSTIC OVARY SYNDROME SYMPTOMS IN WOMEN UNDERGOING INFERTILITY TREATMENT: A RANDOMIZED CONTROLLED CLINICAL TRIAL. THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF YOGA EXERCISES ON ANTHROPOMETRIC PARAMETER AND CLINICAL SIGN OF PCOS AMONG WOMEN UNDERGOING INFERTILITY TREATMENT. THIS CLINICAL TRIAL STUDY WAS PERFORMED ON 61 WOMEN WITH PCOS WHO HAVE UNDERGONE INFERTILITY TREATMENT AT SAREM HOSPITAL IN TEHRAN, IRAN. THE PATIENTS WERE FIRST SELECTING BASED ON PURPOSEFUL AND THEN RANDOMLY ASSIGNING TO THE INTERVENTION AND CONTROL GROUPS. IN THE INTERVENTION GROUP, YOGA EXERCISES WERE PERFORMED FOR 6 WEEKS AND THE PATIENTS IN THE CONTROL GROUP ONLY RECEIVED ROUTINE CARE. ANTHROPOMETRIC PARAMETERS AND CLINICAL SIGNS WERE PERFORMED AND RECORDED. AFTER THE INTERVENTION, HERE WAS A SIGNIFICANT REDUCTION IN HIRSUTISM, ABDOMINAL CIRCUMFERENCE, AND HIP CIRCUMFERENCE SCORES IN THE INTERVENTION GROUP COMPARED TO THE CONTROL GROUP (P < 0.05). GIVEN THE EFFECTS OF YOGA EXERCISES ON THE IMPROVEMENT OF HIRSUTISM, ABDOMINAL CIRCUMFERENCE, AND HIP CIRCUMFERENCE, IT IS SUGGESTED TO USE YOGA AS A TREATMENT STRATEGY IN WOMEN WITH PCOS. 2021 17 2363 31 VOLUNTARILY INDUCED VOMITING - A YOGA TECHNIQUE TO ENHANCE PULMONARY FUNCTIONS IN HEALTHY HUMANS. VOMITING IS A COMPLEX AUTONOMIC REFLEX ORCHESTRATED BY SEVERAL NEUROLOGICAL CENTRES IN THE BRAIN. VAGUS, THE CRANIAL NERVE PLAYS A KEY ROLE IN REGULATION OF VOMITING. KUNJAL KRIYA (VOLUNTARILY INDUCED VOMITING), IS A YOGIC CLEANSING TECHNIQUE WHICH INVOLVES VOLUNTARILY INDUCING VOMITING AFTER DRINKING SALINE WATER (5%) ON EMPTY STOMACH. THIS STUDY WAS DESIGNED WITH AN OBJECTIVE TO UNDERSTAND THE EFFECT OF VOLUNTARY INDUCED VOMITING (VIV) ON PULMONARY FUNCTIONS IN EXPERIENCED PRACTITIONERS AND NOVICES AND DERIVE ITS POSSIBLE THERAPEUTIC APPLICATIONS. EIGHTEEN HEALTHY INDIVIDUALS VOLUNTEERED FOR THE STUDY OF WHICH NINE HAD PRIOR EXPERIENCE OF VIV WHILE NINE DID NOT. PULMONARY FUNCTION TESTS WERE PERFORMED BEFORE AND AFTER 10 MIN OF REST FOLLOWING VIV. ANALYSIS OF COVARIANCE WAS PERFORMED ADJUSTED FOR GENDER AND BASELINE VALUES. NO SIGNIFICANT CHANGES WERE OBSERVED ACROSS GENDERS. THE RESULTS OF THE PRESENT STUDY SUGGEST A SIGNIFICANT INCREASE IN SLOW VITAL CAPACITY [F(1,13) = 5.699; P = 0.03] AND FORCED INSPIRATORY VOLUME IN 1ST SECOND [P = 0.02] AND REDUCTION IN EXPIRATORY RESERVE VOLUME [F(1,13) = 5.029; P = 0.04] AND RESPIRATORY RATE [F(1,13) = 3.244, P = 0.09]. THESE CHANGES SUGGEST THE POSSIBLE ROLE OF VIV IN ENHANCING THE ENDURANCE OF THE RESPIRATORY MUSCLES, DECREASED AIRWAY RESISTANCE, BETTER EMPTYING OF LUNGS AND VAGAL PREDOMINANCE RESPECTIVELY. WE CONCLUDE THAT VIV WHEN PRACTICED REGULARLY ENHANCES THE ENDURANCE OF THE RESPIRATORY MUSCLES AND DECREASES AIRWAY RESISTANCE. THESE FINDINGS ALSO INDICATE NEED FOR SCIENTIFIC UNDERSTANDING OF VIV IN THE MANAGEMENT OF MOTION SICKNESS AND RESTRICTIVE PULMONARY DISORDERS LIKE BRONCHITIS AND BRONCHIAL ASTHMA. 2018 18 1462 44 INFLUENCE OF YOGA ON POSTOPERATIVE OUTCOMES AND WOUND HEALING IN EARLY OPERABLE BREAST CANCER PATIENTS UNDERGOING SURGERY. CONTEXT: PRE- AND POSTOPERATIVE DISTRESS IN BREAST CANCER PATIENTS CAN CAUSE COMPLICATIONS AND DELAY RECOVERY FROM SURGERY. OBJECTIVE: THE AIM OF OUR STUDY WAS TO EVALUATE THE EFFECTS OF YOGA INTERVENTION ON POSTOPERATIVE OUTCOMES AND WOUND HEALING IN EARLY OPERABLE BREAST CANCER PATIENTS UNDERGOING SURGERY. METHODS: NINETY-EIGHT RECENTLY DIAGNOSED STAGE II AND III BREAST CANCER PATIENTS WERE RECRUITED IN A RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECTS OF A YOGA PROGRAM WITH SUPPORTIVE THERAPY AND EXERCISE REHABILITATION ON POSTOPERATIVE OUTCOMES AND WOUND HEALING FOLLOWING SURGERY. SUBJECTS WERE ASSESSED AT THE BASELINE PRIOR TO SURGERY AND FOUR WEEKS LATER. SOCIODEMOGRAPHIC, CLINICAL AND INVESTIGATIVE NOTES WERE ASCERTAINED IN THE BEGINNING OF THE STUDY. BLOOD SAMPLES WERE COLLECTED FOR ESTIMATION OF PLASMA CYTOKINES-SOLUBLE INTERLEUKIN (IL)-2 RECEPTOR (IL-2R), TUMOR NECROSIS FACTOR (TNF)-ALPHA AND INTERFERON (IFN)-GAMMA. POSTOPERATIVE OUTCOMES SUCH AS THE DURATION OF HOSPITAL STAY AND DRAIN RETENTION, TIME OF SUTURE REMOVAL AND POSTOPERATIVE COMPLICATIONS WERE ASCERTAINED. WE USED INDEPENDENT SAMPLES T TEST AND NONPARAMETRIC MANN WHITNEY U TESTS TO COMPARE GROUPS FOR POSTOPERATIVE OUTCOMES AND PLASMA CYTOKINES. REGRESSION ANALYSIS WAS DONE TO DETERMINE PREDICTORS FOR POSTOPERATIVE OUTCOMES. RESULTS: SIXTY-NINE PATIENTS CONTRIBUTED DATA TO THE CURRENT ANALYSIS (YOGA: N = 33, CONTROL: N = 36). THE RESULTS SUGGEST A SIGNIFICANT DECREASE IN THE DURATION OF HOSPITAL STAY (P = 0.003), DAYS OF DRAIN RETENTION (P = 0.001) AND DAYS FOR SUTURE REMOVAL (P = 0.03) IN THE YOGA GROUP AS COMPARED TO THE CONTROLS. THERE WAS ALSO A SIGNIFICANT DECREASE IN PLASMA TNF ALPHA LEVELS FOLLOWING SURGERY IN THE YOGA GROUP (P < 0.001), AS COMPARED TO THE CONTROLS. REGRESSION ANALYSIS ON POSTOPERATIVE OUTCOMES SHOWED THAT THE YOGA INTERVENTION AFFECTED THE DURATION OF DRAIN RETENTION AND HOSPITAL STAY AS WELL AS TNF ALPHA LEVELS. CONCLUSION: THE RESULTS SUGGEST POSSIBLE BENEFITS OF YOGA IN REDUCING POSTOPERATIVE COMPLICATIONS IN BREAST CANCER PATIENTS. 2008 19 1461 46 INFLUENCE OF YOGA ON MOOD STATES, DISTRESS, QUALITY OF LIFE AND IMMUNE OUTCOMES IN EARLY STAGE BREAST CANCER PATIENTS UNDERGOING SURGERY. CONTEXT: BREAST CANCER PATIENTS AWAITING SURGERY EXPERIENCE HEIGHTENED DISTRESS THAT COULD AFFECT POSTOPERATIVE OUTCOMES. AIMS: THE AIM OF OUR STUDY WAS TO EVALUATE THE EFFECTS OF YOGA INTERVENTION ON MOOD STATES, TREATMENT-RELATED SYMPTOMS, QUALITY OF LIFE AND IMMUNE OUTCOMES IN BREAST CANCER PATIENTS UNDERGOING SURGERY. SETTINGS AND DESIGN: NINETY-EIGHT RECENTLY DIAGNOSED STAGE II AND III BREAST CANCER PATIENTS WERE RECRUITED FOR A RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECTS OF A YOGA PROGRAM WITH SUPPORTIVE THERAPY PLUS EXERCISE REHABILITATION ON POSTOPERATIVE OUTCOMES FOLLOWING SURGERY. MATERIALS AND METHODS: SUBJECTS WERE ASSESSED PRIOR TO SURGERY AND FOUR WEEKS THEREAFTER. PSYCHOMETRIC INSTRUMENTS WERE USED TO ASSESS SELF-REPORTED ANXIETY, DEPRESSION, TREATMENT-RELATED DISTRESS AND QUALITY OF LIFE. BLOOD SAMPLES WERE COLLECTED FOR ENUMERATION OF T LYMPHOCYTE SUBSETS (CD4 %, CD8 % AND NATURAL KILLER (NK) CELL % COUNTS) AND SERUM IMMUNOGLOBULINS (IGG, IGA AND IGM). STATISTICAL ANALYSIS USED: WE USED ANALYSIS OF COVARIANCE TO COMPARE INTERVENTIONS POSTOPERATIVELY. RESULTS: SIXTY-NINE PATIENTS CONTRIBUTED DATA TO THE CURRENT ANALYSIS (YOGA N = 33, CONTROL N = 36). THE RESULTS SUGGEST A SIGNIFICANT DECREASE IN THE STATE (P = 0.04) AND TRAIT (P = 0.004) OF ANXIETY, DEPRESSION (P = 0.01), SYMPTOM SEVERITY (P = 0.01), DISTRESS (P < 0.01) AND IMPROVEMENT IN QUALITY OF LIFE (P = 0.01) IN THE YOGA GROUP AS COMPARED TO THE CONTROLS. THERE WAS ALSO A SIGNIFICANTLY LESSER DECREASE IN CD 56% (P = 0.02) AND LOWER LEVELS OF SERUM IGA (P = 0.001) IN THE YOGA GROUP AS COMPARED TO CONTROLS FOLLOWING SURGERY. CONCLUSIONS: THE RESULTS SUGGEST POSSIBLE BENEFITS FOR YOGA IN REDUCING POSTOPERATIVE DISTRESS AND PREVENTING IMMUNE SUPPRESSION FOLLOWING SURGERY. 2008 20 962 44 EFFECTS OF A YOGA PROGRAM ON CORTISOL RHYTHM AND MOOD STATES IN EARLY BREAST CANCER PATIENTS UNDERGOING ADJUVANT RADIOTHERAPY: A RANDOMIZED CONTROLLED TRIAL. UNLABELLED: OBJECTIVES. THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY AT A CANCER CENTER. METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS ARE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO RADIOTHERAPY TREATMENT. ASSESSMENTS INCLUDE DIURNAL SALIVARY CORTISOL LEVELS 3 DAYS BEFORE AND AFTER RADIOTHERAPY AND SELF-RATINGS OF ANXIETY, DEPRESSION, AND STRESS COLLECTED BEFORE AND AFTER 6 WEEKS OF RADIOTHERAPY. RESULTS: ANALYSIS OF COVARIANCE REVEALS SIGNIFICANT DECREASES IN ANXIETY (P < .001), DEPRESSION (P = .002), PERCEIVED STRESS (P < .001), 6 A.M. SALIVARY CORTISOL (P = .009), AND POOLED MEAN CORTISOL (P = .03) IN THE YOGA GROUP COMPARED WITH CONTROLS. THERE IS A SIGNIFICANT POSITIVE CORRELATION BETWEEN MORNING SALIVARY CORTISOL LEVEL AND ANXIETY AND DEPRESSION. CONCLUSION: YOGA MIGHT HAVE A ROLE IN MANAGING SELF-REPORTED PSYCHOLOGICAL DISTRESS AND MODULATING CIRCADIAN PATTERNS OF STRESS HORMONES IN EARLY BREAST CANCER PATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. 2009